HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Andrew J. Murday Tom Treasure Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Unsworth-White, M. J. Articles by Treasure, T. Search for Related Content PubMed PubMed Citation Articles by Unsworth-White, M. J. Articles by Treasure, T.

Ann Thorac Surg 1995;59:664-667
© 1995 The Society of Thoracic Surgeons

Resternotomy for Bleeding After Cardiac Operation: A Marker for Increased Morbidity and Mortality

Cardiothoracic Unit, St. George's Hospital, London, United Kingdom

Accepted for publication November 15, 1994.

Over a 2-year period from January 1, 1992, to December 31, 1993, of 2,221 patients undergoing cardiac operations in our unit, 85 (3.8%) were reopened for the control of bleeding (9 patients more than once). The incidence of resternotomy in coronary cases was 2.3%, but resternotomy was more than three times as likely in valve cases (odds ratio, 3.4; 95% confidence interval, 2.1 to 5.4). Previous cardiac operation was more common among resternotomy patients than among the remainder (18% versus 9%, respectively; p = 0.018). An identifiable source of bleeding was found in 57 of the 85 patients (67%), but a concurrent coagulopathy was common (45 patients). Resternotomy patients, as a group, had higher preoperative risk scores (Parsonnet) than did the other patients (p < 0.0001), stayed longer in the intensive care unit (p < 0.0001), and had greater requirements for intraaortic balloon counterpulsation (14% versus 3%) and hemofiltration (9% versus 3%) (p < 0.0001 and p < 0.01, respectively). Nineteen resternotomy patients (22%) died in the hospital, a proportion significantly greater than the risk assigned to this group of patients preoperatively (12.8%) (p = 0.008). In contrast, the observed mortality for the other 2,136 patients (5.5%) was significantly less (8.3%) (p < 0.00006). Multiple forward stepwise logistic-regression analysis confirmed resternotomy for excessive bleeding after cardiac operation to be a significant independent predictor of a prolonged stay in the intensive care unit (p < 0.0001), the need for intraaortic balloon counterpulsation (p < 0.0001), and death (p < 0.0001).

This article has been cited by other articles:

				L. J. Bowman, W. E. Uber, M. R. Stroud, L. R. Christiansen, J. Lazarchick, A. J. Crumbley III, J. M. Kratz, J. M. Toole, F. A. Crawford Jr, and J. S. Ikonomidis Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery. Ann. Thorac. Surg., May 1, 2008; 85(5): 1669 - 1677. [Abstract] [Full Text] [PDF]

				K. Karkouti, W. S. Beattie, M. A. Crowther, J. L. Callum, R. Chun, S. E. Fremes, J. Lemieux, V. C. McAlister, B. D. Muirhead, J. M. Murkin, et al. The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference: [Le role du facteur VIIa recombinant dans la chirurgie cardiaque avec circulation extra-corporelle : Rapport de la Conference canadienne de consensus] Can J Anesth, July 1, 2007; 54(7): 573 - 582. [Abstract] [Full Text] [PDF]

				P. M. Mannucci and M. Levi Prevention and Treatment of Major Blood Loss N. Engl. J. Med., May 31, 2007; 356(22): 2301 - 2311. [Full Text] [PDF]

				C. K. Choong, C. Gerrard, K. A. Goldsmith, H. Dunningham, and A. Vuylsteke Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 834 - 838. [Abstract] [Full Text] [PDF]

				W. Cohn, I. D. Gregoric, and O.H. Frazier Staged Reoperation: A Novel Strategy for High-Risk Patients Ann. Thorac. Surg., April 1, 2007; 83(4): 1558 - 1559. [Abstract] [Full Text] [PDF]

				C. W. Hogue and M. J. London Aprotinin Use During Cardiac Surgery: A New or Continuing Controversy? Anesth. Analg., November 1, 2006; 103(5): 1067 - 1070. [Full Text] [PDF]

				A. Kulik, F. D. Rubens, T. G. Mesana, and B.-K. Lam Early postoperative anticoagulation: more questions than answers? Ann. Thorac. Surg., October 1, 2006; 82(4): 1573 - 1574. [Full Text] [PDF]

				K. Karkouti, R. O'Farrell, T. M. Yau, W. S. Beattie, and for the Reducing Bleeding in Cardiac Surgery (RBC) Prediction of massive blood transfusion in cardiac surgery: [La prediction d'une transfusion massive en cardiochirurgie]. Can J Anesth, August 1, 2006; 53(8): 781 - 794. [Abstract] [Full Text] [PDF]

				K. Karkouti, T. M. Yau, S. Riazi, K. M. Dattilo, M. Wasowicz, M. Meineri, S. A. McCluskey, D. N. Wijeysundera, A. van Rensburg, and W. S. Beattie Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery: [Les determinants de complications avec le facteur VIIa recombinant utilise pour les pertes sanguines refractaires en chirurgie cardiaque]. Can J Anesth, August 1, 2006; 53(8): 802 - 809. [Abstract] [Full Text] [PDF]

				H. Pleym, A. Wahba, V. Videm, A. Asberg, S. Lydersen, L. Bjella, O. Dale, and R. Stenseth Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery. Anesth. Analg., March 1, 2006; 102(3): 660 - 667. [Abstract] [Full Text] [PDF]

				A. Kulik, F. D. Rubens, P. S. Wells, C. Kearon, T. G. Mesana, J. van Berkom, and B.-K. Lam Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review Ann. Thorac. Surg., February 1, 2006; 81(2): 770 - 781. [Abstract] [Full Text] [PDF]

				C. P. Charalambous, C. S. Zipitis, and D. J. Keenan Chest Reexploration in the Intensive Care Unit After Cardiac Surgery: A Safe Alternative to Returning to the Operating Theater Ann. Thorac. Surg., January 1, 2006; 81(1): 191 - 194. [Abstract] [Full Text] [PDF]

				N. Luciani, A. Anselmi, M. Gaudino, G. Nasso, F. Glieca, L. Martinelli, F. Santarelli, M. Perisano, and G. Possati Harmonic Scalpel Reduces Bleeding and Postoperative Complications in Redo Cardiac Surgery Ann. Thorac. Surg., September 1, 2005; 80(3): 934 - 938. [Abstract] [Full Text] [PDF]

				T. A. Khan, C. Bianchi, P. Voisine, J. Sandmeyer, J. Feng, and F. W. Sellke Aprotinin Inhibits Protease-Dependent Platelet Aggregation and Thrombosis Ann. Thorac. Surg., May 1, 2005; 79(5): 1545 - 1550. [Abstract] [Full Text] [PDF]

				R. J. DiDomenico, M. G. Massad, J. Kpodonu, R. A. Navarro, and A. S. Geha Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass Chest, May 1, 2005; 127(5): 1828 - 1835. [Abstract] [Full Text] [PDF]

				T. Treasure Mortality in adult cardiac surgery BMJ, March 5, 2005; 330(7490): 489 - 490. [Full Text] [PDF]

				T. L. Frankel, S. C. Stamou, R. C. Lowery, E. I. Kapetanakis, P. C. Hill, E. Haile, and P. J. Corso Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 494 - 500. [Abstract] [Full Text] [PDF]

				S. Karthik, A. D. Grayson, E. E. McCarron, D. M. Pullan, and M. J. Desmond Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay Ann. Thorac. Surg., August 1, 2004; 78(2): 527 - 534. [Abstract] [Full Text] [PDF]

				J. J. Andreasen and C. Nielsen Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 311 - 317. [Abstract] [Full Text] [PDF]

				T. Athanasiou, P. Kumar, S. Al-Ruzzeh, O. Aziz, A. Charitou, J. Hart, B. Glenville, and R. Casula Expanded use of suction and stabilization devices in cardiothoracic surgery Ann. Thorac. Surg., October 1, 2003; 76(4): 1126 - 1130. [Abstract] [Full Text] [PDF]

				Y. Deng, K. Byth, and H. S Paterson Age and Left Ventricular Impairment Predict Reopening for Bleeding Asian Cardiovasc Thorac Ann, June 1, 2003; 11(2): 147 - 152. [Abstract] [Full Text] [PDF]

				H. Pleym, R. Stenseth, A. Wahba, L. Bjella, A. Karevold, and O. Dale Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery Anesth. Analg., April 1, 2003; 96(4): 923 - 928. [Abstract] [Full Text] [PDF]

				L. Y Lee, W. DeBois, K. H Krieger, L. N Girardi, L. Russo, J. McVey, W. Ko, N. K Altorki, R. A Brodman, and O W. Isom The effects of platelet inhibitors on blood use in cardiac surgery Perfusion, January 1, 2002; 17(1): 33 - 37. [Abstract] [PDF]

				J. M. Alvarez, L. R. Jackson, C. Chatwin, and J. J. Smolich Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective, randomized, double-blind, placebo-controlled trial J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 457 - 463. [Abstract] [Full Text] [PDF]

				S. M. Fiser, C. G. Tribble, J. A. Kern, S. M. Long, A. K. Kaza, and I. L. Kron Cardiac reoperation in the intensive care unit Ann. Thorac. Surg., June 1, 2001; 71(6): 1888 - 1893. [Abstract] [Full Text] [PDF]

				V. Casati, D. Guzzon, M. Oppizzi, F. Bellotti, A. Franco, C. Gerli, M. Cossolini, G. Torri, G. Calori, S. Benussi, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 520 - 527. [Abstract] [Full Text] [PDF]

				L. V. Doering, F. Esmailian, and H. Laks Perioperative Predictors of ICU and Hospital Costs in Coronary Artery Bypass Graft Surgery Chest, September 1, 2000; 118(3): 736 - 743. [Abstract] [Full Text] [PDF]

				S. C. Silvestry and P. K. Smith Current status of cardiac surgery in the abciximab-treated patient Ann. Thorac. Surg., August 1, 2000; 70(2): S12 - 19. [Abstract] [Full Text] [PDF]

				D R Lawrence, O Valencia, E E J Smith, A Murday, and T Treasure Parsonnet score is a good predictor of the duration of intensive care unit stay following cardiac surgery Heart, April 1, 2000; 83(4): 429 - 432. [Abstract] [Full Text]

				J. J. Munoz, N. J. O. Birkmeyer, J. D. Birkmeyer, G. T. O'Connor, and L. J. Dacey Is {epsilon}-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? : A Meta-Analysis Circulation, January 12, 1999; 99(1): 81 - 89. [Abstract] [Full Text] [PDF]

				M. P. Pelletier and R. C.-J. Chiu Reply Ann. Thorac. Surg., October 1, 1998; 66(4): 1472 - 1472. [Full Text] [PDF]

				M. P. Pelletier, S. Solymoss, A. Lee, and R. C.-J. Chiu Negative Reexploration for Cardiac Postoperative Bleeding: Can It Be Therapeutic? Ann. Thorac. Surg., April 1, 1998; 65(4): 999 - 1002. [Abstract] [Full Text] [PDF]

				L. J. Dacey, J. J. Munoz, Y. R. Baribeau, E. R. Johnson, S. J. Lahey, B. J. Leavitt, R. D. Quinn, W. C. Nugent, J. D. Birkmeyer, G. T. O'Connor, et al. Reexploration for Hemorrhage Following Coronary Artery Bypass Grafting: Incidence and Risk Factors Arch Surg, April 1, 1998; 133(4): 442 - 447. [Abstract] [Full Text] [PDF]

				M. J. Moulton, L. L. Creswell, M. E. Mackey, J. L. Cox, and M. Rosenbloom REEXPLORATION FOR BLEEDING IS A RISK FACTOR FOR ADVERSE OUTCOMES AFTER CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 1037 - 1046. [Abstract] [Full Text]